Clinical Trials in New York

Showing 2561-2580 of 19,464 trials

IN10018 Monotherapy and Combination Therapy for Metastatic Melanoma

NCT04109456

This is a phase Ib, open label clinical study to evaluate the safety, tolerability, PK and antitumor activities of IN10018 as monotherapy and in combination with cobimetinib in subjects with metastatic uveal melanoma and NRAS-mutant metastatic melanoma.

Metastatic Melanoma

InxMed (Shanghai) Co., Ltd.51 participantsStarted Mar 2020

Miami, Florida, United States • Boston, Massachusetts, United States • Boston, Massachusetts, United States +5 more locations

Active Not RecruitingPhase 3< 1 mile

Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Immunotherapy (ASCENT-GYN-01/GOG-3104/ENGOT-en26)

NCT06486441

The goal of this clinical study is to find out how the study drug, sacituzumab govitecan (SG) works in participants with endometrial cancer who have received prior treatment with platinum-based chemotherapy and immunotherapy, versus the treatment of physician's choice (TPC). The primary objectives of this study are to evaluate the effect of SG compared to TPC on progression-free survival (PFS) as assessed by blinded independent central review (BICR) and overall survival (OS).

Endometrial Cancer

Gilead Sciences640 participantsStarted Aug 2024

Little Rock, Arkansas, United States • Duarte, California, United States • La Jolla, California, United States +186 more locations

IN10018 Monotherapy and Combination Therapy for Metastatic Melanoma

Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Immunotherapy (ASCENT-GYN-01/GOG-3104/ENGOT-en26)

Find Trials by Condition in New York

Stress Phenotypes and Preterm Birth

Study BT7480-100 in Patients With Advanced Malignancies Associated With Nectin-4 Expression

Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma

Enhanced Recovery After Major Surgery and Chronic Pain for Total Knee Arthroplasty

Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial

Living Healthy for Moms RCT

Bupropion to Reduce Cancer Related Fatigue in Cancer Survivors

Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study

Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)

Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2)

Artificial Urinary Sphincter Clinical Outcomes

A Study of Cytisinicline for Smoking Cessation in Adult Smokers

Veterans Coordinated Community Care (3C) Study

Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer

A Study of DM005 in Patients With Advanced Solid Tumors

Randomized, Open-label, Two-arms, Phase III Comparative Study Assessing the Role of Involved Mediastinal Radiotherapy After Rituximab Containing Chemotherapy Regimens to Patients With Newly Diagnosed Primary Mediastinal Large B-Cell Lymphoma

Study of Serine Supplementation to Protect Vision in MacTel

Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in Pediatric PID Patients (KIDCARES10)